Literature DB >> 26214030

Successful treatment with intravenous recombinant tissue plasminogen activator in an acute stroke patient presenting with hemiballism.

Jan Paweł Bembenek, Marta Bilik, Anna Członkowska.   

Abstract

A 79-year-old woman with hypertension was evaluated 3 hours and 20 minutes after the sudden onset of left-sided weakness which lasted about 15 minutes and was followed by involuntary, coarse, flinging movements of the left extremities (hemiballistic), occurring every few minutes, and facial asymmetry. Brain computed tomography revealed no abnormalities. The patient received intravenous thrombolysis with 0.9 mg/kg of alteplase 4 hours after the symptom onset. Involuntary movements and central facial nerve paresis subsided within 48 hours of the thrombolysis. Magnetic resonance imaging at day 5 revealed restricted diffusion within the right globus pallidus, which was a new ischemic lesion. Thrombolysis should be considered in hemiballism as a presenting symptom of acute stroke.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26214030      PMCID: PMC4520676     

Source DB:  PubMed          Journal:  Funct Neurol        ISSN: 0393-5264


  10 in total

1.  Long-term prognosis of vascular hemiballismus.

Authors:  Aleksandar Ristic; Jelena Marinkovic; Natasa Dragasevic; Dejana Stanisavljevic; Vladimir Kostic
Journal:  Stroke       Date:  2002-08       Impact factor: 7.914

2.  Antithrombotic and thrombolytic therapy for ischemic stroke: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Maarten G Lansberg; Martin J O'Donnell; Pooja Khatri; Eddy S Lang; Mai N Nguyen-Huynh; Neil E Schwartz; Frank A Sonnenberg; Sam Schulman; Per Olav Vandvik; Frederick A Spencer; Pablo Alonso-Coello; Gordon H Guyatt; Elie A Akl
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Successful intravenous thrombolysis in a stroke patient with hemiballism.

Authors:  Jasna Zidverc-Trajković; Dejana R Jovanović; Ivan Marjanović; Aleksandra Radojičić; Ljiljana Beslać-Bumbaširević
Journal:  Neurologist       Date:  2011-07       Impact factor: 1.398

4.  Zero on the NIHSS does not equal the absence of stroke.

Authors:  Sheryl Martin-Schild; Karen C Albright; Jessica Tanksley; Vijay Pandav; Elizabeth B Jones; James C Grotta; Sean I Savitz
Journal:  Ann Emerg Med       Date:  2010-09-15       Impact factor: 5.721

5.  Hyperkinetic movement disorders during and after acute stroke: the Lausanne Stroke Registry.

Authors:  F Ghika-Schmid; J Ghika; F Regli; J Bogousslavsky
Journal:  J Neurol Sci       Date:  1997-03-10       Impact factor: 3.181

6.  Hemichorea after stroke: clinical-radiological correlation.

Authors:  Sun J Chung; Joo-Hyuk Im; Myoung C Lee; Jong S Kim
Journal:  J Neurol       Date:  2004-06       Impact factor: 4.849

7.  Hemiballism-hemichorea. Clinical and pharmacologic findings in 21 patients.

Authors:  R B Dewey; J Jankovic
Journal:  Arch Neurol       Date:  1989-08

Review 8.  Movement disorders after stroke.

Authors:  Alexandra Handley; Pippa Medcalf; Kate Hellier; Dipankar Dutta
Journal:  Age Ageing       Date:  2009-03-10       Impact factor: 10.668

Review 9.  Movement disorders in cerebrovascular disease.

Authors:  Raja Mehanna; Joseph Jankovic
Journal:  Lancet Neurol       Date:  2013-04-19       Impact factor: 44.182

10.  Resolution of acute onset hemichorea-hemiballismus after treatment with intravenous tissue plasminogen activator.

Authors:  D McCollum; S Silvers; S B Dawson; K M Barrett
Journal:  Neurohospitalist       Date:  2013-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.